All posts from in,

Heng Ren Investments: Raise Buyout Offer of China Nepstar Chain Drug Store by 86%

Without any challenges, the de-listings of these stocks just sail through bureaucracies at the companies (Special Committees and Boards of Directors), and also the NYSE and Nasdaq. Someone vested in the process needs to oversee and make sure shareholder protections are respected. This is a void Heng Ren is trying to fill by alerting the investment public with research and analysis since many of the stocks are uncovered, and even if covered, lazily by Wall Street.

You may recall in April when a buyer's group including the former co-Chairwoman proposed to buy out shareholders of the of China, (Nasdaq: DATE) at a very low price of $5.37. Heng Ren challenged the bid with valuation analysis it sent in a "fight letter" to the Special Committee and published it for all shareholders and investors. In May the SC responded with the announcement of a revised bid of $7.20, a 34% increase that added $61 million in value for shareholders. The SC also announced at that time there were additional bids received, but oddly the SC to date has not disclosed the identities or the amounts (??).

When Heng Ren started in its activism, the universal opinion was Heng Ren would have no impact. Now other shareholders are following in theirfootsteps to do the same in seeking fair and full value of buyouts. This important story is being missed by the mainstream media. It involves cross-border investments between two superpowers, and highlights a need to avoid more stress on the relationship and negative perceptions of China in the US. This should be resolved fairly by US institutions, in particular the exchanges and regulators, in the interest of investors, current and future US-listed Chinese stocks, and also the reputations of both Nasdaq and NYSE.

This also is getting a lot of attention in China. On a popular investor web site in China called "Snowball," Chinese investors have made more than 530,000 downloads of Heng Ren research and postings. Increasingly, investors in China are eager for professional analysis and to learn more about shareholder protections.

Press release below

Heng Ren Investments: Raise Buyout Offer of China Nepstar Chain Drug Store by 86%

Appeals to Nepstar's Board of Directors and Special Committee; Advised by...